Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharma-Bio Serv (PBSV) Other Non Operating Income (2016 - 2023)

Pharma-Bio Serv (PBSV) has disclosed Other Non Operating Income for 10 consecutive years, with $126985.0 as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Other Non Operating Income changed N/A year-over-year to $126985.0, compared with a TTM value of $133314.0 through Jul 2023, changed N/A, and an annual FY2021 reading of $2.0 million, up 2967.96% over the prior year.
  • Other Non Operating Income was $126985.0 for Q3 2023 at Pharma-Bio Serv, up from $4404.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $2.0 million in Q3 2021 and bottomed at -$30198.0 in Q3 2020.
  • Average Other Non Operating Income over 4 years is $259938.2, with a median of $3403.0 recorded in 2021.
  • The sharpest move saw Other Non Operating Income skyrocketed 6566.98% in 2021, then tumbled 79.12% in 2022.
  • Year by year, Other Non Operating Income stood at -$30198.0 in 2020, then skyrocketed by 104.34% to $1310.0 in 2021, then soared by 236.18% to $4404.0 in 2022, then soared by 2783.4% to $126985.0 in 2023.
  • Business Quant data shows Other Non Operating Income for PBSV at $126985.0 in Q3 2023, $4404.0 in Q2 2022, and $615.0 in Q1 2022.